Sign up for our eNewsletter
[f] [t] [in] [blog]

Portfolio Companies

Bioscience
Clean Technology
Information Technology
Medical Device

Melinta Therapeutics (formerly Rib-X Pharmaceuticals)

CEO: Mary Szela

Year Established: 2000

Description: Melinta Therapeutics, Inc. is an antibiotics company engaged in the discovery, development and commercialization of antibiotics to overcome drug-resistant, life-threatening infections. Melinta was formerly known as Rib-X Pharmaceuticals, and changed its name to Melinta Therapeutics, Inc. on October 7, 2013.

Web: http://www.melinta.com/

CI Representative:
Daniel Wagner
Managing Director, Investments

[photo]